Invention Grant
- Patent Title: Furopyridines as bromodomain inhibitors
-
Application No.: US14770922Application Date: 2014-03-12
-
Publication No.: US09670221B2Publication Date: 2017-06-06
- Inventor: Dominique Amans , Paul Bamborough , Michael David Barker , Rino Antonio Bit , John Alexander Brown , Matthew Campbell , Neil Stuart Garton , Matthew J. Lindon , Tracy Jane Shipley , Natalie Hope Theodoulou , Christopher Roland Wellaway , Susan Marie Westaway
- Applicant: GlaxoSmithKline Intellectual Property (No.2) Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
- Current Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Jane F. Djung; Kathryn A. Lutomski
- International Application: PCT/EP2014/054796 WO 20140312
- International Announcement: WO2014/140077 WO 20140918
- Main IPC: C07D491/048
- IPC: C07D491/048 ; A61K31/496 ; A61K31/4355 ; A61K31/4545 ; A61K31/5377 ; A61K31/5025 ; A61K31/541 ; A61K31/551 ; A61K31/553 ; A61K31/554 ; C07D519/00
Abstract:
The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.
Public/Granted literature
- US20160016966A1 FUROPYRIDINES AS BROMODOMAIN INHIBITORS Public/Granted day:2016-01-21
Information query
